These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 37278746)
1. Relationship between the concentration of ergothioneine in plasma and the likelihood of developing pre-eclampsia. Kenny LC; ; Brown LW; Ortea P; Tuytten R; Kell DB Biosci Rep; 2023 Jul; 43(7):. PubMed ID: 37278746 [TBL] [Abstract][Full Text] [Related]
2. Dose-related relationship between ergothioneine concentrations and risk of preeclampsia. Ho KM Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37602425 [TBL] [Abstract][Full Text] [Related]
3. L-(+)-Ergothioneine Significantly Improves the Clinical Characteristics of Preeclampsia in the Reduced Uterine Perfusion Pressure Rat Model. Williamson RD; McCarthy FP; Manna S; Groarke E; Kell DB; Kenny LC; McCarthy CM Hypertension; 2020 Feb; 75(2):561-568. PubMed ID: 31865793 [TBL] [Abstract][Full Text] [Related]
4. Effect of L-Ergothioneine on the metabolic plasma profile of the RUPP rat model of pre-eclampsia. Morillon AC; Williamson RD; Baker PN; Kell DB; Kenny LC; English JA; McCarthy FP; McCarthy C PLoS One; 2020; 15(3):e0230977. PubMed ID: 32231385 [TBL] [Abstract][Full Text] [Related]
5. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy. Hofmeyr GJ; Manyame S Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011192. PubMed ID: 28949421 [TBL] [Abstract][Full Text] [Related]
6. The potential therapeutic effects of ergothioneine in pre-eclampsia. Kerley RN; McCarthy C; Kell DB; Kenny LC Free Radic Biol Med; 2018 Mar; 117():145-157. PubMed ID: 29284116 [TBL] [Abstract][Full Text] [Related]
7. Adequately diversified dietary intake and iron and folic acid supplementation during pregnancy is associated with reduced occurrence of symptoms suggestive of pre-eclampsia or eclampsia in Indian women. Agrawal S; Fledderjohann J; Vellakkal S; Stuckler D PLoS One; 2015; 10(3):e0119120. PubMed ID: 25785774 [TBL] [Abstract][Full Text] [Related]
8. Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Sharma JB; Sharma A; Bahadur A; Vimala N; Satyam A; Mittal S Int J Gynaecol Obstet; 2006 Jul; 94(1):23-7. PubMed ID: 16730727 [TBL] [Abstract][Full Text] [Related]
9. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation. Litwinska M; Litwinska E; Lisnere K; Syngelaki A; Wright A; Nicolaides KH Ultrasound Obstet Gynecol; 2021 Jul; 58(1):67-76. PubMed ID: 33645854 [TBL] [Abstract][Full Text] [Related]
10. Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death. Erez O; Romero R; Vaisbuch E; Mazaki-Tovi S; Kusanovic JP; Chaiworapongsa T; Than NG; Gotsch F; Kim CJ; Mittal P; Edwin S; Pacora P; Kim SK; Yeo L; Mazor M; Hassan SS J Matern Fetal Neonatal Med; 2009 Aug; 22(8):662-71. PubMed ID: 19591071 [TBL] [Abstract][Full Text] [Related]
11. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers. Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818 [TBL] [Abstract][Full Text] [Related]
12. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D status is associated with uteroplacental dysfunction indicated by pre-eclampsia and small-for-gestational-age birth in a large prospective pregnancy cohort in Ireland with low vitamin D status. Kiely ME; Zhang JY; Kinsella M; Khashan AS; Kenny LC Am J Clin Nutr; 2016 Aug; 104(2):354-61. PubMed ID: 27357092 [TBL] [Abstract][Full Text] [Related]
14. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Hofmeyr GJ; Lawrie TA; Atallah AN; Duley L; Torloni MR Cochrane Database Syst Rev; 2014 Jun; (6):CD001059. PubMed ID: 24960615 [TBL] [Abstract][Full Text] [Related]
15. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. Hofmeyr GJ; Manyame S; Medley N; Williams MJ Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011192. PubMed ID: 31523806 [TBL] [Abstract][Full Text] [Related]
16. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962 [TBL] [Abstract][Full Text] [Related]
17. Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models. Murtoniemi K; Villa PM; Matomäki J; Keikkala E; Vuorela P; Hämäläinen E; Kajantie E; Pesonen AK; Räikkönen K; Taipale P; Stenman UH; Laivuori H BMC Pregnancy Childbirth; 2018 Jul; 18(1):279. PubMed ID: 29970026 [TBL] [Abstract][Full Text] [Related]
19. The biology of ergothioneine, an antioxidant nutraceutical. Borodina I; Kenny LC; McCarthy CM; Paramasivan K; Pretorius E; Roberts TJ; van der Hoek SA; Kell DB Nutr Res Rev; 2020 Dec; 33(2):190-217. PubMed ID: 32051057 [TBL] [Abstract][Full Text] [Related]
20. Mushrooms: A rich source of the antioxidants ergothioneine and glutathione. Kalaras MD; Richie JP; Calcagnotto A; Beelman RB Food Chem; 2017 Oct; 233():429-433. PubMed ID: 28530594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]